BioAtla, Inc. — Director's Dealing 2022

Jun 18, 2022

SEC Form 4/A — Form 4/A

Issuer: BioAtla, Inc. (BCAB)
CIK: 0001826892
Period of Report: 2021-06-15

Reporting Person: MCBRINN SYLVIA (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-15	Stock Option (right to buy)	$39.64	A	18920	Acquired	2031-06-15	Common Stock (18920)	Direct

Footnotes

F1: On June 17, 2021, the reporting person filed a Form 4 in respect of an option covering 24,615 shares. Such option was granted on June 15, 2021 pursuant to the Company's non-employee director compensation policy. The Company subsequently determined that 5,695 of the shares comprising such award were null and void upon grant as a result of the $750,000 annual limit for non-employee director compensation under its 2020 Equity Incentive Plan.

F2: 1/3 of the total number of shares subject to the option shall vest and become exercisable on the earlier of (a) June 15, 2022 or (b) the next annual meeting of stockholders, and 1/36th of the total number of shares shall vest monthly thereafter, subject to the reporting person continuing to provide services to the Company through the vesting date.